<p>(<b>A</b>) Replicons were treated with the indicated concentration of ribavirin for 48 h. The expression of total p53, phosphorylated p53 at Ser15 (p53ser15∼<i>pi</i>) and HCV NS3 viral proteins was analyzed by immunoblotting. The experiment was independently repeated 5 times and one representative result was shown here. The band intensity of each protein in each experiment was determined by densitometry. The expression fold change of proteins were calculated by dividing the band intensity of the indicated proteins, normalized to that of the loading control β-actin, with that observed in the samples receiving no ribavirin treatment. The results are illustrated by the bar graph located on the right side of the Western blot analysis. Each ...
<div><p>Background</p><p>Ribavirin (RBV) is a potential partner of interferon-based therapy and rece...
Ribavirin (RBV) is a potential partner of interferon-based therapy and recently approved therapy usi...
Lethal mutagenesis, or virus extinction produced by enhanced mutation rates, is under investigation ...
<p>Lentiviral vector-mediated silencing of endogenous p53 in replicon cells (JFH1/HepG2) treated wit...
<p>The scrambled-shRNA and p53-shRNA transduced replicon cells (JFH1/HepG2) were treated with IFN-α ...
<p>(a) Huh-7.5 reporter cells were infected with HCVp0 at a MOI of 1–2 TCID<sub>50</sub>/cell (10<su...
AbstractThe recent development of in vitro hepatitis C virus (HCV) RNA replication systems has provi...
<p>(<b>A</b>) Dose-dependent phosphorylation of ERK1/2 by ribavirin. HepG2 cells were treated for 24...
<p>(A) The knockdown efficiency of shRNAs targeting <i>RPS9, RPS15A, RPS20</i> and <i>RPL6</i>. Huh7...
Background/Aims: Ribavirin significantly enhances the antiviral response of interferon-alpha (IFN-al...
Ribavirin significantly enhances the antiviral response of interferon-α (IFN-α) against Hepatitis C ...
BACKGROUND/AIMS: Ribavirin significantly enhances the antiviral response of interferon-α (IFN-α) aga...
<div><h3>Background/Aims</h3><p>Ribavirin significantly enhances the antiviral response of interfero...
Objective: Ribavirin improves treatment response to pegylated-interferon (PEG-IFN) in chronic hepati...
Abstract Background Given the side effects associated with intravenous injections of interferon, an ...
<div><p>Background</p><p>Ribavirin (RBV) is a potential partner of interferon-based therapy and rece...
Ribavirin (RBV) is a potential partner of interferon-based therapy and recently approved therapy usi...
Lethal mutagenesis, or virus extinction produced by enhanced mutation rates, is under investigation ...
<p>Lentiviral vector-mediated silencing of endogenous p53 in replicon cells (JFH1/HepG2) treated wit...
<p>The scrambled-shRNA and p53-shRNA transduced replicon cells (JFH1/HepG2) were treated with IFN-α ...
<p>(a) Huh-7.5 reporter cells were infected with HCVp0 at a MOI of 1–2 TCID<sub>50</sub>/cell (10<su...
AbstractThe recent development of in vitro hepatitis C virus (HCV) RNA replication systems has provi...
<p>(<b>A</b>) Dose-dependent phosphorylation of ERK1/2 by ribavirin. HepG2 cells were treated for 24...
<p>(A) The knockdown efficiency of shRNAs targeting <i>RPS9, RPS15A, RPS20</i> and <i>RPL6</i>. Huh7...
Background/Aims: Ribavirin significantly enhances the antiviral response of interferon-alpha (IFN-al...
Ribavirin significantly enhances the antiviral response of interferon-α (IFN-α) against Hepatitis C ...
BACKGROUND/AIMS: Ribavirin significantly enhances the antiviral response of interferon-α (IFN-α) aga...
<div><h3>Background/Aims</h3><p>Ribavirin significantly enhances the antiviral response of interfero...
Objective: Ribavirin improves treatment response to pegylated-interferon (PEG-IFN) in chronic hepati...
Abstract Background Given the side effects associated with intravenous injections of interferon, an ...
<div><p>Background</p><p>Ribavirin (RBV) is a potential partner of interferon-based therapy and rece...
Ribavirin (RBV) is a potential partner of interferon-based therapy and recently approved therapy usi...
Lethal mutagenesis, or virus extinction produced by enhanced mutation rates, is under investigation ...